Glad we didn't do deal a year ago: DuPont CEO

Edward Breen, DuPont chairman & CEO, and Andrew Liveris, Dow Chemical chairman & CEO, discuss the importance of getting the right management team in place. And Jim Cramer wants to know if Nelson Peltz's Trian Partners or other activist shareholders had an impact on the deal. I believe Third Point gets a major win out of this, says Liveris.